MISP: "Real-world evidence of the impact of access, knowledge, and counseling about the etonogestrel-releasing implant (Implanon NXT®) and the effect on pregnancy rate, reasons and rates for discontinuation, and continuation rate up to two years after insertion in a Brazilian clinic when compared to short-acting reversible contraceptives (SHARC)."

Financing : Schering-Plough Industria Farmacêutica Ltda.

Researcher : Dr. Luis Bahamondes

Line of Research : Contraception, Sexual and Reproductive Health, Immigrants



Associated Search:

To provide a wide comprehension of the MISP implementation status, mechanisms, and objectives (types and delivery modes) among Venezuelan migrants in Roraima State, Brazil – Phase 1 e 2

Financing : WHO – World Health Organization

Researcher : Dr. Luis Bahamondes